DEA Issues Initial Medical Marijuana Dispensary Registrations

November 16, 2026By Larry K. Houck —

The Drug Enforcement Administration (“DEA”) has issued the first registrations to more than 900 qualifying state-licensed medical marijuana dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia.  The registrations mark the first phase of implementing the Attorney General’s April 23, 2026, order establishing a federal regulatory framework for qualifying medical marijuana businesses under the federal Controlled Substances Act (“CSA”).  Each registered dispensary satisfied federal requirements of licensure by a state with medical marijuana regulatory regime consistent with CSA requirements.  The dispensaries were also subject to a DEA pre-registration on-site inspection.

Attorney General Todd Blanche noted that “[t]he regulated distribution of medical marijuana by the applicants that have been granted registration by the Drug Enforcement Administration will help ensure broader access to chronic pain treatment and the safety of the American people.”  The Attorney General further warned that “The Department of Justice will continue prosecuting illegal marijuana trafficking and related criminal activity in accordance with federal law.”

The registered dispensaries submitted applications within the 60-day timeframe following DEA’s April 28, 2026, final rule.  Qualifying applicants are required to operate under a state medical marijuana regulatory regime and the United States’ international treaty obligations.  They are subject to applicable federal schedule III recordkeeping, reporting, inventory, and security requirements.  Registered dispensers may dispense marijuana and products containing marijuana to individuals authorized by state law to possess marijuana and products containing marijuana.  21 C.F.R. § 1301.13(k)(1)(i).

DEA is processing and reviewing additional applications for medical marijuana dispensers, manufacturers, and distributors.  Registered manufacturers will cultivate, produce, process, package, label, and transfer marijuana and products containing marijuana to registered distributors and other registered manufacturers.  21 C.F.R. § 1301.13(k)(1)(i).  Registered distributors will be authorized to receive marijuana and products containing marijuana from registered manufacturers and transfer marijuana and products containing marijuana to registered dispensers and other registered distributors.  21 C.F.R. § 1301.13(k)(1)(ii).  All manufacturing, distribution, and dispensing will be subject to the registrants’ state licenses.

Qualifying medical marijuana dispensaries, manufacturers, and distributors who applied within the initial 60-day timeframe and whose applications are pending may continue engaging in medical marijuana activities and transact with qualified applicants and with newly DEA-registered dispensaries while their applications are pending.

The Attorney General’s April order applies to defined qualifying medical marijuana activities.  It does not authorize recreational marijuana or other marijuana activities outside of the order’s scope, which remain a schedule I controlled substance.